A curated collection of federal funding opportunities, specifically tailored for minority-owned biotechnology enterprises. This list highlights grants from the SBIR, STTR, and NIH programs that address the unique challenges of early-stage scientific innovation and healthcare disparity research.
Get targeted exposure with custom position pinning and highlighted placement.
The Small Business Innovation Research (SBIR) Phase I program provides non-dilutive funding of up to $300,000 for initial proof-of-concept work. It is designed for small businesses to develop innovative biotechnological solutions, with specific priority areas for minority-owned enterprises focusing on health disparity research.
The Small Business Technology Transfer (STTR) program requires collaboration with a non-profit research institution, making it ideal for academic spinouts. It offers up to $300,000 for initial feasibility studies, ensuring that minority-owned biotech firms can leverage institutional resources while maintaining IP ownership.
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) offers grants for technologies that advance imaging, biosensors, and biomaterials. Minority-owned startups in this niche can access targeted funding to develop diagnostic tools and therapeutic devices that address underrepresented patient populations.
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) funds research into the biological mechanisms of alcohol use disorders. Minority-owned biotech firms can pursue grants focusing on health disparities, developing personalized treatments, or creating novel pharmacotherapies for alcohol-related conditions.
The National Cancer Institute (NCI) prioritizes research in early detection, treatment, and prevention of cancer. Minority-owned biotech startups can leverage these specific SBIR and STTR solicitations to fund innovative oncology projects, particularly those addressing higher incidence or mortality rates in minority communities.
While primarily a certification program, the 8(a) Business Development Program provides access to set-aside government contracts and mentoring. Minority-owned biotech firms gain critical business development support and guaranteed access to certain federal procurement opportunities that are unavailable to non-certified companies.
The Centers for Disease Control and Prevention (CDC) offers grants for public health improvement, including biotech applications in epidemiology and diagnostics. Minority-owned startups can apply for funding to develop tools that monitor disease outbreaks or improve health outcomes in underserved communities.
The Office of Minority Health (OMH) provides direct funding for projects that aim to eliminate health disparities. Minority-owned biotech firms can secure grants for developing culturally competent health technologies, educational tools, or biomedical interventions specifically designed for racial and ethnic minority groups.
The Food and Drug Administration (FDA) supports pre-market research and development through its SBIR/STTR programs. Minority-owned biotech startups can fund early-stage development of novel medical devices, biologics, or drug delivery systems, with a focus on improving regulatory science and patient safety.
The National Science Foundation (NSF) funds early-stage R&D in engineering and life sciences. Minority-owned biotech companies can apply for NSF SBIR grants to develop novel bioengineering applications, synthetic biology tools, or advanced materials that do not fall strictly under NIH or USDA mandates.
The Department of Agriculture (USDA) supports biotech innovations in agriculture and food safety. Minority-owned startups can pursue grants for developing sustainable bioproducts, plant-based solutions, or agricultural technologies that enhance food security, particularly in minority-serving institutions or communities.
The Department of Defense (DoD) Peer-Reviewed Cancer Research Program funds promising new avenues for cancer treatment. Minority-owned biotech firms can apply for grants to develop novel therapeutics or diagnostic platforms, with a specific emphasis on improving outcomes for diverse cancer patient populations.
The Agency for Healthcare Research and Quality (AHRQ) funds research to improve patient safety and quality of care. Minority-owned biotech companies can develop digital health tools, decision-support systems, or safety devices that reduce medical errors and improve equity in healthcare delivery.
The Health Resources and Services Administration (HRSA) supports workforce training and community health initiatives. Minority-owned biotech startups can collaborate on grants to develop training technologies or community-based health interventions that address gaps in healthcare access for minority populations.
The Department of Energy (DOE) funds research in energy biosciences, including biofuels and sustainable manufacturing. Minority-owned biotech firms can pursue grants to develop bio-based materials, renewable energy solutions, or industrial bioprocesses that contribute to environmental justice and sustainable economic growth.
The I-Corps program provides entrepreneurial training and funding to help scientists commercialize their research. Minority-owned biotech founders can access this resource to validate market fit, refine business models, and prepare for subsequent grant applications, bridging the gap between lab discovery and market entry.
Various states offer additional grant programs for minority-owned businesses, often aligned with federal initiatives. Startups should explore state-specific economic development agencies that provide supplementary funding, tax incentives, or matching grants to support local biotech innovation ecosystems.
This NIH center specifically funds research to reduce health disparities among racial and ethnic minority groups. Minority-owned biotech firms can leverage this targeted funding to develop interventions, diagnostic tools, or therapeutic strategies that directly address the biological and social determinants of health in these populations.
The National Institute of Mental Health (NIMH) funds innovative approaches to mental health disorders. Minority-owned biotech startups can apply for grants to develop novel digital therapeutics, pharmacological treatments, or diagnostic assays for mental health conditions prevalent in minority communities.
The Substance Abuse and Mental Health Services Administration (SAMHSA) offers awards for innovative prevention and treatment approaches. Minority-owned biotech companies can secure funding to develop technologies that improve access to mental health services, reduce stigma, or enhance treatment efficacy in underserved minority groups.